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Abstract  34 
Human flavin-containing monooxygenase 3 (hFMO3) is a drug-metabolizing enzyme capable 35 
of performing N- or S-oxidation using the C4a-hydroperoxy intermediate. In this work, we 36 
employ both wild type hFMO3 as well as an active site polymorphic variant (N61S) to unravel 37 
the uncoupling reactions in the catalytic cycle of this enzyme. We demonstrate that in addition 38 
to H2O2 this enzyme also produces superoxide anion radicals as its uncoupling products. The 39 
level of uncoupling was found to vary between 50 and 70% (WT) and 90 to 98% (N61S) for 40 
incubations with NADPH and benzydamine over a period of 5 or 20 minutes, respectively. For 41 
the first time, we were able to follow the production of the superoxide radical in hFMO3, which 42 
was found to account for 13-18% of the total uncoupling of this human enzyme. Moreover, 43 
measurements in the presence or absence of the substrate show that the substrate lowers the 44 
level of uncoupling only related to the H2O2 and not the superoxide radical. This is consistent 45 
with the entry point of the substrate in this enzyme’s catalytic cycle. 46 
These findings highlight the importance of the involvement of hFMO3 in the production of 47 
radicals in the endoplasmic reticulum, as well as the relevance of single-nucleotide 48 
polymorphism leading to deleterious effects of oxidative stress.   49 
 50 
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1. Introduction 55 
Human flavin-containing monooxygenase 3 (hFMO3) is a drug metabolizing enzyme expressed 56 
at high levels in the human liver [1-3]. Human FMO3 is the major human enzyme able to perform 57 
the monooxygenation of trimethylamine (TMA) yielding trimethylamine N-oxide (TMAO) [4]. 58 
Impaired metabolism of its main substrate TMA is known to cause trimethylaminuria, a genetic 59 
disease in which affected individuals present high levels of TMA in both sweat and urine leading 60 
to a displeasing body odor [5,6]. The disease is caused by mutations of the hFMO3 gene that 61 
cause an altered activity of the enzyme and have direct consequences on the oxidation of TMA. 62 
One such mutation, N61S, leads to a polymorphic variant known to cause trimethylaminuria [7]. 63 
On the other hand, the product of the reaction, TMAO, was recently found to be a risk factor for 64 
cardiovascular disease [8-10].  65 
Previous characterization of pig liver FMO has shown how FMO is reduced by NADPH and 66 
upon binding of O2 it can form a stable long-lived C4a-hydroperoxyflavin intermediate [11,12]. 67 
This species reacts very well with soft nucleophiles performing a monooxygenase reaction, 68 
followed by the formation of water and the release of the oxidized NADP+ cofactor [11,12]. 69 
Nevertheless, recent work carried out with purified human FMO1, FMO2, FMO3 and FMO5 70 
have demonstrated how the human enzyme does not seem to form a long-lived intermediate 71 
and that the detachment of oxygen species from peroxyflavin might lead to uncoupling [13- 16]. 72 
The uncoupling reaction, which is defined as the wastage of electrons and oxygen without 73 
oxidation of the substrate, can lead to the formation of reactive oxygen species (ROS) such as 74 
the superoxide radical and/or hydrogen peroxide. Earlier studies performed with pig FMO have 75 
highlighted the formation of superoxide anion radical at the rate of about 4% the total NADPH 76 
oxidized [17]. Formation of hydrogen peroxide, up to 41% of the total NADPH oxidized, has 77 
also been demonstrated in earlier work with purified rabbit lung FMO [18]. However, more 78 
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recently the human FMOs 1, 2 and 3 were found to release only H2O2 after reduction by NADPH 79 
with no superoxide radical being observed [16].  80 
In this work, since we had previously purified hFMO3 [19] and its polymorphic N61S variant 81 
[13], we set out to measure the uncoupling products of these enzymes in order to clarify whether 82 
the human enzyme also produces the superoxide radical or only hydrogen peroxide. To do so, 83 
we tested the ability of the enzyme to use the electrons provided by NADPH to perform the 84 
monooxygenation reaction, by quantifying both the amount of ROS (hydrogen peroxide and 85 
superoxide radical) and product formed. The N61S polymorphic variant was selected due to its 86 
poor binding affinity for NADP+ leading to an acceleration of the C4a-hydroperoxyFAD 87 
intermediate decay [13], resulting in higher uncoupling. 88 
 89 
2. Material and Methods  90 
2.1 Cloning, expression and purification  91 
The pJL2-hFMO3 plasmid constructed previously [19, 20] was used with QuikChange® site-92 
directed mutagenesis kit (Stratagene) to produce N61S hFMO3 [13]. Human FMO3 gene 93 
containing a C-terminal poly-histidine tag was heterologously expressed in E. coli cells and 94 
purified as described previously [21].  The protein was stored at -80 ºC in 50 mM KPi pH 7.4, 95 
20% glycerol with 1 mM EDTA. Protein purity and concentration was determined 96 
spectroscopically as described previously [13, 22]. 97 
2.2 NADPH oxidation, hydrogen peroxide and superoxide detection 98 
All the reactions were carried out in the dark, in triplicates, in 96-well plates using a plate reader 99 
equipped with a uv-vis absorbance detector using 1.6 µM hFMO3, 160 µM NADPH and 0 or 100 
300 µM benzydamine in 50 mM KPi pH 7.4. The optical pathlength was 0.45 cm. The plate 101 
reader automatically takes into account the optical pathlength on the basis of the volume used 102 
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in the 96-well plates. For NADPH consumption reactions, mixtures were incubated at 37 °C. 103 
NADPH signal at 340 nm was monitored in time using 6220 M–1 cm–1 as extinction coefficient. 104 
Preliminary controls were performed to establish reaction conditions that do not lead to 105 
undesired production of hydrogen peroxide by NADPH autoxidation. The controls are shown in 106 
Figure S1 where incubations of AMPLEX RED kit are reported with or without NADPH. Results 107 
indicate that under our experimental conditions there is no detectable contribution to hydrogen 108 
peroxide formation by NADPH. Basal NADPH consumption in the absence of the substrate was 109 
also tested (Figure S2). 110 
Potential interference of benzydamine with the Amplex Red assay was evaluated by comparing 111 
identical assay conditions in the presence or absence of benzydamine. Figure S3 shows that 112 
there is no interference with the assay. 113 
For every assay aimed at the quantification of hydrogen peroxide the amount of hydrogen 114 
peroxide in the unknown sample was determined using a calibration curve prepared with fresh 115 
hydrogen peroxide and run in parallel with the unknown samples. 116 
For H2O2 detection 50 μL of reaction mixture was withdrawn from a well at each time point and 117 
mixed in an eppendorf containing 50 μL of cold acetonitrile to terminate the reaction, centrifuged 118 
at 14000 rpm for 5 minutes and subjected to HPLC separation. The remaining 50 μL of reaction 119 
mixtures were incubated with AMPLEX RED [16, 23, 24] and H2O2 formation was quantified at 120 
571 nm by recording the spectrum of resorufin after 1 minute of incubation for each time point. 121 
In the absence of benzydamine all the steps were identical, but the reactions were not subjected 122 
to HPLC. In order to assess if benzydamine can be oxidized non-enzymatically by H2O2 a 123 
reaction control was performed by incubating 20 µM of with benzydamine at 37°C for 1 hour. 124 
The concentration of was chosen to reproduce the highest amount of present in the reaction 125 
mixture produced by the enzyme.  126 
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For superoxide radical detection, in order to exclude that the signal of cytochrome c reduction 127 
is not due to superoxide, 2 control reactions were performed. In the first control, the cytochrome 128 
c reduction experiment was performed in the presence of SOD using 10 µM of cytochrome c. 129 
Figure S4, clearly shows that at this cytochrome c concentration there is no direct cytochrome 130 
c reduction by the enzyme. In the second control, cytochrome c reduction was performed in the 131 
absence/presence of SOD using 50 µM of cytochrome c. The data presented in Figure S5, 132 
demonstrate that at this higher cytochrome c concentration there is a contribution of hFMO3 to 133 
direct cytochrome c reduction. Therefore, only the SOD inhibited part of the signal can be used 134 
to measure superoxide. The amount of superoxide matches what was previously found using 135 
10 µM cytochrome c that is the optimal concentration to test cytochrome c reduction without 136 
the interference of direct reduction from hFMO3 by cytochrome c. 137 
To calculate the amount of superoxide produced by hFMO3 an extinction coefficient of 2.1x10^4 138 
M-1cm-1 was used which is the difference in the extinction coefficients between the reduced and 139 
oxidized forms and it was used because it takes into account only the amount of superoxide 140 
that is actually formed during the reaction. All analyses were carried out using 10 µM horse 141 
heart cytochrome c (Sigma).  142 
 143 
2.3 HPLC analysis 144 
N-oxygenation of benzydamine by the wild type and N61S variant of hFMO3 were carried out 145 
as previously described [24, 25] and the amount of product determined by HPLC (Agilent-1200, 146 
Agilent Technologies, U.S.A.). Each sample was analyzed by HPLC equipped with 4.6×150 147 
mm 5 μm Eclipse XDB-C18 column at room temperature with the UV–visible detector set at 148 
308 nm for benzydamine N-oxide as described previously [25]. 149 
 150 
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2.4 Calculation of the percentage of uncoupling 151 
 152 
Uncoupling percentages were calculated by dividing the absolute rates of the rates of 153 
benzydamine oxidation by the NADPH consumption which yields the coupled reaction. The 154 
uncoupled reaction is given by the subtraction of the coupled reaction from the total reaction 155 
(including both coupled and uncoupled reactions).  156 
 157 
2.5 Differential scanning calorimetry 158 
In order to provide direct effects of hydrogen peroxide exposure differential scanning 159 
calorimetry experiments were carried out for hFMO3 following incubation of the enzyme with 160 
hydrogen peroxide. Differential scanning calorimetry was carried out as previously illustrated 161 
[13] 162 
 163 
2.6 Statistical analyses  164 
Statistical analyses were performed using Sigmaplot 11.0 software. Data calculations were 165 
carried out by repeated-measures of two-way ANOVA followed by Student-Newman-Keuls post 166 
hoc test. All experiments were executed in triplicates. Data are shown as mean ± standard 167 
deviation. Differences among data points were considered significant when p < 0.05.  168 
 169 
3. Results  170 
In order to measure the uncoupling reactions of hFMO3, the NADPH oxidation activity of the 171 
purified WT enzyme was investigated by monitoring the kinetics of the decrease in absorbance 172 
of the reduced cofactor at 340 nm in time. NADPH by itself shows minimal oxidation in the 173 
absence of the enzyme, so the reaction can actually start only when both NADPH and hFMO3 174 
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are present (data not shown). The amount of H2O2 produced was measured by mixing aliquots 175 
of each reaction, at different times after the start, with the AMPLEX red kit components [23]. 176 
We compared the H2O2 produced by WT hFMO3 and its polymorphic variant, N61S. The latter, 177 
an active site mutant associated with trimethylaminuria is known to have impaired NADP+ 178 
binding and lower activity [13]. The data obtained demonstrate how in the absence of the 179 
substrate benzydamine (BZD), N61S produces higher amounts of H2O2 compared to WT (Fig 180 
1). Interestingly WT showed steadily increased leakage while N61S had high leakage at the 181 
beginning of the incubation that decreased slowly after the first 15 minutes.  182 
A)          B) 183 
  184 
Fig. 1. H2O2 generation for WT and N61S hFMO3. The amount of hydrogen peroxide was 185 
measured for WT (black) and N61S mutant (red) hFMO3 as a function of time after the reaction 186 
is started. A) Generation of hydrogen peroxide in the first 5 minutes. B) Generation of hydrogen 187 
peroxide for 60 minutes. Reaction conditions for the production of hydrogen peroxide: 1.6 µM 188 
hFMO3 with 160 µM NADPH at 37°C in the dark in 50 mM KPi at pH 7.4. For detection of 189 
hydrogen peroxide refer to Materials and Methods.   190 
 191 
If we look at the overall rate of H2O2 production by hFMO3 (Fig 2) the data are in agreement 192 
with recently published data [16] for this enzyme (0.5–2.5 nmol/min/nmol FMO at pH 7.4).   193 
 10 
 194 
Fig. 2. Rate of H2O2 formation. Calculation of the rate is performed using the linear range of 195 
the kinetics curve between 60 and 180 seconds. Reaction conditions for the production of 196 
hydrogen peroxide: 1.6 µM hFMO3 and 160 µM NADPH at 37°C in the dark in 50 mM KPi, pH 197 
7.4. 198 
 199 
 200 
Moreover, in order to better understand what is the real level of uncoupling in hFMO3, we also 201 
measured the amount of product (benzydamine N-oxide) formed as a function of NADPH 202 
consumed. As expected the WT enzyme shows overall lower uncoupling (50-70%) when 203 
compared to N61S (90-95%), as shown in Figure 3.  204 
A)            B)     C) 205 
   206 
 11 
Fig. 3. Enzyme coupling efficiency. A) Oxidation of NADPH B) Product formation measured 207 
as benzydamine N-oxide C) Ratio between the amount of benzydamine N-oxide formed and 208 
the amount of NADPH consumed for WT (black) and N61S mutant (red) hFMO3. Reaction 209 
conditions for the production of hydrogen peroxide: 1.6 µM hFMO3, 160 µM NADPH with 300 210 
µM benzydamine at 37°C in the dark in 50 mM KPi at pH 7.4. 211 
 212 
 213 
Further characterization of the uncoupling process was carried out by measuring H2O2 214 
production under different conditions to assess the specific contribution of the substrate 215 
benzydamine (BZD), in the presence of catalase (CAT) and superoxide dismutase (SOD). For 216 
both WT and N61S enzymes the presence of substrate significantly lowers the formation of 217 
H2O2 (Figure 4A, B, Figure S6). As expected, catalase totally removed the H2O2 from the 218 
reaction mixtures, so no H2O2 was detected (data not shown). On the other hand, superoxide 219 
dismutase in the absence of substrate, increased the amount of H2O2 detected after 15 and 30 220 
minutes suggesting the possible formation of superoxide radical (i.e. since superoxide 221 
dismutase catalyzes the disproportionation of superoxide into O2 and H2O2, an increase in H2O2 222 
is indicative of the presence of the superoxide radical) (Figure 4A).   223 
 224 
* 
* 
* 
* * 
* * * 
* 
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 225 
 226 
Fig. 4. Effect of substrate, catalase (CAT) and superoxide dismutase (SOD) on H2O2 227 
generation. Data obtained WT (top) and N61S (bottom) hFMO3 after 5 (black), 15 (red) or 30 228 
(blue) minutes. Bars represent the mean ± standard deviation. Statistically different (*) from 229 
same time of different group, p < 0.05. Reaction conditions: 1.6 µM hFMO3, 160 µM NADPH, 230 
2 µM SOD with 2 µM catalase at 37°C in the dark in 50 mM KPi at pH 7.4. 231 
 232 
 233 
Subsequently, the amount of benzydamine N-oxide product formed in the absence or presence 234 
of catalase/superoxide dismutase was also calculated. For WT both catalase and superoxide 235 
dismutase have a slightly negative impact after 15 minutes on the amount of product formed 236 
(Figure 5A). In the case of N61S variant, catalase has a positive impact on catalysis after 15 237 
minutes whereas superoxide dismutase does not seem to affect product formation. 238 
 239 
 240 
 241 
 242 
 243 
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 245 
 246 
Fig. 5. Effect of substrate, catalase (CAT) and superoxide dismutase (SOD) on 247 
benzydamine N-oxide product formation.  Data obtained WT (top) and N61S (bottom) 248 
hFMO3 after 5 (black), 15 (red) or 30 (blue) minutes. Bars represent the mean ± standard 249 
deviation. Statistically different (*) from same time of different groups, p < 0.05. Reaction 250 
conditions: 1.6 µM hFMO3, 160 µM NADPH, 300 µM benzydamine, 2 µM SOD and 2 µM 251 
catalase at 37°C in the dark in 50 mM KPi at pH 7.4. 252 
 253 
 254 
Given the above measured contribution of superoxide dismutase to H2O2 production and to 255 
clarify whether hFMO3 can actually form the superoxide radical, a cytochrome c reduction 256 
assay was carried out [17]. The control reaction was performed using superoxide dismutase to 257 
* 
* 
* 
* 
* 
* 
* 
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eliminate any source of superoxide (data not shown). As shown in Figure 6, cytochrome c 258 
reduction clearly shows how both WT and N61S hFMO3 are able to form the superoxide radical 259 
and that N61S forms twice as much superoxide reaching 4 µM after 5 minutes. 260 
 261 
Fig. 6. Generation of superoxide. WT (black) and N61S mutant (red) hFMO3. A) Cytochrome 262 
c reduction in the absence of benzydamine. B) Cytochrome c reduction in the presence of 263 
benzydamine.  Reaction conditions: 1.6 µM hFMO3, 160 µM NADPH, 300 µM benzydamine, 264 
10 µM cytochrome c with 2 µM SOD at 37°C in the dark in 50 mM KPi at pH 7.4. 265 
 266 
 267 
Finally, taken all the data together the total amount of uncoupling measured for both hFMO3 268 
and its N61S polymorphic variant was converted into percentages (see Materials and methods 269 
section). In the case of the WT enzyme, after 10 min of incubation with the substrate, ~62% 270 
uncoupling was calculated of which 48% is due to hydrogen peroxide with remaining 14% due 271 
to superoxide radical formation. On the other hand, under the same experimental conditions, 272 
the N61S polymorphic variant is ~98% uncoupled with 80% from hydrogen peroxide and 18% 273 
from superoxide formation. 274 
 275 
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4. Discussion 277 
Mechanistic studies carried out on pig liver FMO during the 1980’s pointed unequivocally 278 
towards a precise scheme: mammalian FMO is reduced by NADPH and upon binding of oxygen 279 
can form a stable C4a-hydroperoxide intermediate [11,12]. It has been postulated that FMO is 280 
present in the cell in this highly reactive form ready to exert catalysis on its substrates [27, 28]. 281 
Such mechanism was also investigated against a large number of substrates and even though 282 
the enzyme shows differential affinity for N- or S- soft nucleophiles, it is thought to lack a proper 283 
binding step during catalysis. According to this scheme, any suitable molecule can be 284 
monooxygenated by FMO, provided that charge and size characteristics are respected [27].  285 
In this context, the uncoupling reactions of FMO and its ability to generate reactive oxygen 286 
species has been considered negligible for a long time. Nevertheless, more recent studies have 287 
highlighted the fact that hFMO3 does not form a highly stable C4a-hydroperoxy intermediate 288 
[13]. UV-vis stopped-flow experiments demonstrated that WT hFMO3 forms an intermediate 289 
that can last for minutes and not for hours [13, 14]. Further characterization of the enzyme led 290 
to the confirmation that NADP+ binding is crucial for the intermediate stability and that an active 291 
site mutant, N61S, dramatically decreases the affinity of the enzyme for the cofactor preventing 292 
the formation of the reaction intermediate [13, 14]. Measured Kd values for NADPH are 0.3 and 293 
51.8 µM for WT and N61S hFMO3, respectively [13].  In the case of NADP+ the binding affinity 294 
for WT is 3.7 µM, whereas for N61S no appreciable binding could be detected [13].  295 
Other published studies on hFMO5 have also pointed towards the absence of a stable 296 
intermediate in the reaction mechanism of the enzyme and suggested the unproductive leakage 297 
of the peroxyflavin [15]. In a recent published work by Williams and colleagues [16] the 298 
uncoupling process of human FMO isoforms 1, 2 and 3 was studied. The latter authors 299 
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demonstrated how all studied isoforms generate H2O2 upon reduction by NADPH, both in the 300 
presence or absence of substrate and, unexpectedly that the presence of substrate even 301 
increased the amount of H2O2 generated by FMO [16]. The same group did not observe any 302 
effect with the addition of catalase or superoxide dismutase to the reaction [16].  303 
In this work, we undertook an extensive characterization of hFMO3 on the basis of the above-304 
mentioned recent findings. For this reason, two purified enzymes were used: wild type hFMO3 305 
and N61S [13]. It was found that both WT and N61S produce H2O2 (Figure 1) with higher 306 
amounts observed with the mutant due to the its inability to bind NADP+ and form a stable C4a-307 
hydroperoxy intermediate. The latter finding suggests that this mutation leads to an overall 308 
faster catalytic cycle that is detrimental for catalysis [13]. This is fully in line with previous 309 
characterization of the rates of formation and decay of the flavin intermediates reported for WT 310 
and N61S hFMO3 [13]. 311 
Subsequently, we focused our attention to the actual meaning of coupling i.e. the use of 312 
electrons donated by NADPH to yield a product molecule. To this end, benzydamine a hFMO3 313 
marker substrate was used and the amount of product was measured as a percentage of the 314 
NADPH consumed. The data confirmed a high degree of uncoupling for hFMO3 and an even 315 
higher increased propensity to the unproductive leakage of electrons for the N61S variant 316 
(Figure 3). More importantly, if the amount of H2O2 produced in the absence/presence of the 317 
substrate is compared, it becomes evident that the presence of the substrate results in a strong 318 
decrease in the amount of H2O2 (Figure 4A, B). The latter observation is actually in line with the 319 
current representation of the catalytic cycle [16].  320 
All these findings indicate that there are competing paths that ultimately lead to the regeneration 321 
of the FAD cofactor: the productive path leads to product oxidation with the unproductive path 322 
leading to the formation of reactive oxygen species. Further analysis shows that both catalase 323 
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and superoxide dismutase slightly decrease the amount of benzydamine N-oxide formed in the 324 
enzymatic reaction for WT and have contrasting effects for N61S (Figure 5A, B). A possible 325 
explanation for the increase in product formation for WT is that N-oxidation can be achieved - 326 
at least to a much lower extent - in the absence of enzyme and only by H2O2, as most N-oxides 327 
are actually synthetized [29]. Nevertheless, our experiments show that incubation of H2O2 with 328 
benzydamine does not lead to non-enzymatic product formation (Figure S7). In the case of 329 
N61S, a significant increase in the amount of product is detected after 30 minutes in presence 330 
of catalase. This could be due to the decreased protein structural damage caused by large 331 
amounts of H2O2 in the absence of catalase after several minutes/catalytic cycles. Our data 332 
indicate that incubation of H2O2 with hFMO3 does not lead to structural damage (Figure S8). 333 
Therefore the increased amount of product formed for N61S can only be compatible with a 334 
higher coupling efficiency in the presence of catalase.   335 
In general, looking at the catalytic cycle of hFMO3 (Fig. 7) a productive oxidative half-cycle 336 
leading to N-oxidation of the substrate and an unproductive oxidative half-cycle leading to H2O2 337 
can clearly be identified. As expected in the presence of the substrate the enzyme uses the 338 
productive path more often as confirmed by data obtained in presence of benzydamine showing 339 
that the presence of this substrate favors the coupled reaction and decreases the amount of 340 
H2O2 formed. Moreover, since a higher amount of H2O2 was observed in the presence of 341 
superoxide dismutase, the possibility of hFMO3 producing the superoxide radical was also 342 
investigated. Cytochrome c reduction experiments confirmed hFMO3 as the source of 343 
superoxide radical. As mentioned earlier, superoxide radical formation had already been 344 
reported for pig FMO but it had been studied in close association to the possible exploitation of 345 
this reactive oxygen species for the hydroxylation of amines [17] and not in the context of the 346 
uncoupling reactions.  347 
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In light of the observed superoxide radical, we propose a second shunt in the catalytic cycle of 348 
hFMO3 consisting of an earlier exit from the productive path (fig. 7, steps a, b). The latter is in 349 
addition to the already reported shunt leading to H2O2 (fig. 7, step c) as mentioned above [16]. 350 
It is known that for the reduced flavin to react with oxygen a “radical pair” between the 351 
superoxide and the flavin semiquinone is formed (fig. 7 step 2) [30]. This species is highly 352 
unstable and it has never been captured [31], but it is chemically required to bypass the spin 353 
inversion barrier [30, 31]. At this point of the cycle the radical pair can either yield the 354 
hydroperoxyflavin (fig. 7 step 3-4) or take an unproductive path and generate a semiquinone 355 
radical with the loss of the superoxide (fig. 7 step a). This semiquinone intermediate can decay 356 
resulting in the re-oxidized flavin with the concomitant production of another superoxide (fig. 7 357 
step b). This new path can explain why after the formation of the caged radical pair, superoxide 358 
can detach from the flavin together with NADP+, short circuiting the catalytic cycle.  359 
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 360 
Fig. 7. Chemical structures of FAD reaction intermediates during the catalytic cycle of 361 
flavin-containing monooxygenases. NADPH reduction (step 1) is rapidly followed by 362 
activation of molecular oxygen (step 2), binding on the C4a and protonation to yield the C4a-363 
hydroperoxide (step 3-4). This intermediate can react with the substrate (S) and yield the 364 
oxygenated product (S-O, step 5). The second atom of oxygen is released as H2O (step 6) and 365 
NADP+ can leave the active site (step 7). Two side reactions can occur that produce reactive 366 
oxygen species: steps a) and b) before formation of the hydroperoxyflavin after spin inversion 367 
of the radical pair which can result in the loss of superoxide or step c) the direct loss of H2O2 368 
from the C4a-hydroperoxy intermediate.  369 
 370 
 20 
The physiological role of the uncoupled reaction products of hFMO3 is still unknown. It has 371 
been suggested that the generation of hydrogen peroxide by FMO could play a role in control 372 
of the overall redox state of the cell [27] or in the synthesis of protein disulfide bonds through 373 
cysteamine oxidation [32, 33]. On the other hand, toxicological effects such as hepatic injury 374 
through radical production and lipid peroxidation have also been reported in rat FMO catalyzing 375 
the oxidation of thioacetamide [34]. Initially it was thought that the products of thioacetamide, 376 
being radicals themselves, were initiating the inflammation and the resulting hepatic injury, but 377 
further investigation suggested the FMO enzyme itself might be involved [35]. Nevertheless, 378 
since this current work and others [16-18] have shown FMO enzymes to be highly uncoupled, 379 
further studies are required to confirm whatever the role of these reactive oxygen species 380 
maybe, physiological or toxicological. 381 
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